| The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation R Knoll, ET Helbig, K Dahm, O Bolaji, F Hamm, O Dietrich, M van Uelft, ... Cell, 2024 | | 2024 |
| Deutlicher Anstieg der Malaria-Todesfälle in Deutschland nach dem Ende der COVID-19-Pandemie F Klitzsch, F Kurth, M Ramharter DMW-Deutsche Medizinische Wochenschrift 149 (13), 792-794, 2024 | | 2024 |
| Significant increase in malaria deaths in Germany after the end of the COVID-19 pandemic F Klitzsch, F Kurth, M Ramharter Deutsche Medizinische Wochenschrift (1946) 149 (13), 792-794, 2024 | | 2024 |
| Anti-inflammatory therapy with nebulised dornase alfa for severe COVID-19 pneumonia JC Porter, J Inshaw, VJ Solis, E Denneny, R Evans, MI Temkin, ... eLife 12, 2024 | | 2024 |
| Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination M Mockel, S Pudasaini, NH Le, D Huscher, F Holert, F Kurth, PT Lau, ... European Heart Journal: Acute Cardiovascular Care 13 (Supplement_1), zuae036 …, 2024 | | 2024 |
| Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung PJ Dörner, H Anandakumar, I Röwekamp, F Fiocca Vernengo, ... Nature Communications 15 (1), 2788, 2024 | | 2024 |
| Clinical spectrum and long-term outcomes of mpox: a cohort study spanning from acute infection to six-month follow-up C Zeyen, M Kinberger, H Kriedemann, F Pfäfflin, P Tober-Lau, L Huang, ... BMC Infectious Diseases 24 (1), 317, 2024 | 2 | 2024 |
| Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses M Lebedin, C Ratswohl, A Garg, M Schips, CV García, L Spatt, ... Iscience 27 (3), 2024 | | 2024 |
| Presence of anti-RBC antibodies correlates with parasitaemia and once-infected RBCs but not the extent of post-malaria haemolysis P Tober-Lau, AK Kneller, T Lingscheid, B Mayer, T Zoller, F Kurth Journal of Travel Medicine, taae045, 2024 | | 2024 |
| A new phenotype of patients with post COVID-19 condition and dyspnoea is characterized by a pattern of complex ventilatory dysfunction, neuromuscular disturbance, and chronic … F Steinbeis, C Kedor, H Meyer, C Thibeault, M Mittermaier, P Knape, ... Pneumologie 78 (S 01), FV 501, 2024 | | 2024 |
| Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early-and late-phase COVID-19 J Radke, J Meinhardt, T Aschman, RL Chua, V Farztdinov, S Lukassen, ... Nature Neuroscience 27 (3), 409-420, 2024 | 6 | 2024 |
| Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics MEH White, LR Sinn, DM Jones, J de Folter, SK Aulakh, Z Wang, ... Nature Biomedical Engineering 8 (3), 233-247, 2024 | 8 | 2024 |
| Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP) F Steinbeis, C Thibeault, S Steinbrecher, Y Ahlgrimm, IA Haack, D August, ... Infection 52 (1), 93-104, 2024 | | 2024 |
| Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: a prospective study on subtle and persistent … M Möckel, S Pudasaini, NH Le, D Huscher, F Holert, D Hillus, ... medRxiv, 2024.05. 10.24307207, 2024 | | 2024 |
| Cross-platform Clinical Proteomics using the Charite Open Standard for Plasma Proteomics (OSPP) Z Wang, V Farztdinov, LR Sinn, P Tober-Lau, D Ludwig, F Amari, ... medRxiv, 2024.05. 10.24307167, 2024 | | 2024 |
| Role of the complement system in Long COVID V Farztdinov, B Zuehlke, F Sotzny, F Steinbeis, M Seifert, C Kedor, ... medRxiv, 2024.03. 14.24304224, 2024 | | 2024 |
| Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients S Leonhardt, C Jürgensen, J Frohme, D Grajecki, A Adler, M Sigal, ... Hepatology International 17 (6), 1610-1625, 2023 | 10 | 2023 |
| Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in severe COVID-19 B Opitz, M Essex, BM Pascual-Leone, U Loeber, M Kuhring, B Zhang, ... | | 2023 |
| Nebulised dornase alfa reduces inflammation and improves clinical outcomes in severe COVID-19: a randomised clinical trial JC Porter, J Inshaw, VJ Solis, E Denneny, R Evans, MI Temkin, ... eLife 12, 2023 | 1 | 2023 |
| 90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection L Bosquillon de Jarcy, B Akbil, B Mhlekude, J Leyens, D Postmus, ... Clinical and Experimental Medicine 23 (7), 3689-3700, 2023 | | 2023 |
Peter G. KremsnerProfessor for Tropical Medicine, Travel Medicine and Parasitology, University of Tübingen在 uni-tuebingen.de 的电子邮件经过验证
